Modern treatment of haemophilia: choice of products for the treatment of haemophilia A and B

This publication has 21 references indexed in Scilit:

• Three-year randomised study of high-purity or intermediate-purity factor VIII concentrates in symptom-free HIV-seropositive haemophiliacs: effects on immune status
  The Lancet, 1993
• Purity of factor VIII concentrates and serial CD4 counts
  The Lancet, 1993
• Coagulation factor IX: Successful surgical experience with a purified factor IX concentrate
  American Journal of Hematology, 1992
• Outbreak of hepatitis A among Italian patients with haemophilia
  The Lancet, 1992
• Incidence of development of factor VIII and factor IX inhibitors in haemophiliacs
  The Lancet, 1992
• T cell sensitization to factor VIII in haemophilia A?
  British Journal of Haematology, 1991
• Intranasal desmopressin (DDAVP) by spray in mild hemophilia A and von Willebrand's disease type I
  Annals of Hematology, 1990
• Inhibition of interleuk:in‐2 secretion by factor VIII concentrates: a possible cause of immunosuppression in haemophiliacs
  British Journal of Haematology, 1989
• Therapy with Factor IX Concentrate Resulting in DIC and Thromboembolic Phenomena
  Transfusion, 1978
• 1-DEAMINO-8-D-ARGININE VASOPRESSIN: A NEW PHARMACOLOGICAL APPROACH TO THE MANAGEMENT OF HAEMOPHILIA AND VON WILLEBRAND'S DISEASE
  The Lancet, 1977